Alan R Tall Selected Research

Insulin Receptor

3/2013	Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice.
4/2006	Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan R Tall Research Topics

Disease

76	Atherosclerosis 03/2024 - 06/2002
21	Atherosclerotic Plaque (Atheroma) 01/2023 - 06/2005
19	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 06/2004
18	Inflammation (Inflammations) 01/2022 - 06/2005
12	Thrombosis (Thrombus) 12/2023 - 11/2007
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 03/2007
8	Coronary Disease (Coronary Heart Disease) 01/2019 - 02/2003
8	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2008
7	Obesity 01/2020 - 03/2004
7	Insulin Resistance 05/2014 - 04/2009
6	Neoplasms (Cancer) 01/2022 - 08/2012
5	Hypercholesterolemia 11/2023 - 11/2007
5	Tangier Disease 01/2018 - 01/2003
5	Myocardial Infarction 01/2018 - 08/2012
4	Necrosis 01/2023 - 06/2007
4	Cholesteryl Ester Transfer Protein Deficiency 01/2018 - 02/2003
4	Leukocytosis (Pleocytosis) 07/2013 - 06/2010
3	Melanoma (Melanoma, Malignant) 01/2023 - 09/2017
3	Dyslipidemias (Dyslipidemia) 01/2022 - 04/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 03/2004
3	Vascular Diseases (Vascular Disease) 01/2017 - 05/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2005
2	Fatty Liver 01/2022 - 01/2016
2	Infections 12/2021 - 02/2015
2	Weight Loss (Weight Reduction) 01/2020 - 05/2014
2	Diabetes Mellitus 01/2019 - 01/2018
2	Leukemia 09/2016 - 02/2013
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2013 - 06/2010
2	Body Weight (Weight, Body) 09/2011 - 01/2005
1	Carotid Artery Thrombosis 12/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Heart Failure 02/2022
1	Peritonitis 01/2022
1	Polycythemia (Erythrocytosis) 01/2022

Drug/Important Bio-Agent (IBA)

60	CholesterolIBA 03/2024 - 06/2002
24	HDL LipoproteinsIBA 01/2021 - 06/2004
16	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2023 - 09/2003
16	LipidsIBA 01/2021 - 06/2002
14	InflammasomesIBA 03/2024 - 01/2018
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2007
11	oxidized low density lipoproteinIBA 01/2022 - 06/2002
11	HDL CholesterolIBA 01/2019 - 02/2003
11	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2017 - 01/2003
10	Apolipoproteins E (ApoE)IBA 01/2020 - 10/2006
9	Lipoproteins (Lipoprotein)IBA 03/2024 - 06/2002
9	Insulin (Novolin)FDA Link 12/2016 - 03/2004
8	Liver X ReceptorsIBA 01/2022 - 11/2003
8	Cholesterol Ester Transfer ProteinsIBA 01/2017 - 06/2002
7	LDL Receptors (LDL Receptor)IBA 01/2023 - 01/2005
7	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2002
6	Adenosine Triphosphate (ATP)IBA 01/2021 - 02/2006
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 01/2005
6	LDL CholesterolIBA 09/2017 - 08/2010
5	ApolipoproteinsIBA 01/2023 - 06/2002
5	Transcription Factors (Transcription Factor)IBA 01/2016 - 11/2003
4	Phospholipids (Phosphatides)FDA LinkGeneric 12/2021 - 01/2003
3	InterleukinsIBA 01/2023 - 01/2018
3	CME-Carbodiimide (CMEC)IBA 11/2022 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2015
3	anacetrapibIBA 01/2018 - 07/2010
3	Apolipoproteins B (ApoB)IBA 05/2012 - 06/2002
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 03/2024 - 11/2017
2	Interleukin-6 (Interleukin 6)IBA 06/2023 - 06/2005
2	canakinumab FDA Link 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Antisense OligonucleotidesIBA 01/2022 - 01/2020
2	Interleukin-18 (Interleukin 18)IBA 01/2019 - 01/2018
2	SterolsIBA 09/2017 - 09/2007
2	Scavenger Receptors (Scavenger Receptor)IBA 09/2017 - 08/2007
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2007
2	evacetrapibIBA 01/2017 - 12/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2016 - 05/2014
2	Interleukin-3 (Interleukin 3)IBA 09/2016 - 05/2014
2	OxysterolsIBA 04/2016 - 02/2010
2	EnzymesIBA 01/2016 - 09/2005
2	TOR Serine-Threonine KinasesIBA 05/2014 - 05/2012
2	Sirolimus (Rapamycin)FDA Link 05/2014 - 05/2012
2	Insulin ReceptorIBA 03/2013 - 04/2006
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 03/2013 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 09/2005
2	torcetrapibIBA 11/2009 - 11/2007
2	Streptozocin (Streptozotocin)FDA Link 09/2005 - 06/2002
1	ThromboxanesIBA 12/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023
1	Deoxyribonuclease I (Nickase)IBA 12/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 12/2023
1	holomycinIBA 11/2023
1	Mitogen-Activated Protein Kinase 8IBA 11/2023
1	Deubiquitinating EnzymesIBA 11/2023
1	Macrophage Colony-Stimulating FactorIBA 06/2023
1	pexidartinibIBA 06/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2023
1	Colchicine FDA LinkGeneric 01/2023
1	CalciumIBA 11/2022
1	Erythropoietin FDA Link 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	liproxstatin-1IBA 01/2022
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2022

Therapy/Procedure

10	Therapeutics 06/2023 - 02/2013
4	Transplantation 05/2014 - 06/2010